ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


A Clinical Review of Antibody- Mediated Pure Red Cell Aplasia
 (Vol 32/No. 1. On-line test expires: 12/20/2006)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Susan Vogel, MHA, RN, CNN
 Susan Vogel, MHA, RN, CNN, the CEO and President of Renal Replacement Therapies, Encino, CA. She is also an Administrator at South Valley Regional Dialysis Center, Inc., Encino, CA; and a member of the Los Angeles chapter of ANNA.
Jérôme Rossert, MD, PhD
 Jérôme Rossert, MD, PhD, is a Professor of Nephrology at the University Pierre and Marie Curie in Paris, France. He is also a Consulting Physician in the Department of Nephrology at Tenon Hospital, Paris, France; and a Senior Scientist at the National Institute for Health and Medical Research (INSERM), Paris, France.
  OUTLINE

Pure red cell aplasia (PRCA) is a rare hematologic disorder characterized by severe anemia from selective failure of the bone marrow to produce mature red blood cells. This disorder can be congenital or acquired from various causes. The development of PRCA in patients with chronic kidney disease receiving recombinant erythropoietin (rHuEPO) for renal anemia has increased in recent years. This review will enable nurses to recognize the pathogenesis, clinical manifestations, and therapeutic options for rHuEPO-induced PRCA.
  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.0 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses’ Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910.

  EDUCATIONAL OBJECTIVES

Goal:
Recognize the clinical manifestations of and therapeutic options for rHuEPO-induced pure red cell aplasia (PRCA).

 Objectives:
1. List the symptoms of PRCA and its causes.
2. Describe the epidemiologic pattern of rHuEPO-induced PRCA.
3. Discuss therapy for rHuEPO-induced PRCA.
AUTHOR DISCLOSURE STATEMENT
Susan Vogel, MHA, RN, CNN has no conflicts of interest to disclose.
Jérôme Rossert, MD, PhD has no conflicts of interest to disclose.

 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.